Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Thomas Noh

Neurological Surgery Boston, MA Medical Doctor

NPI 1417210584 CMS profile 858654

75 Francis St Dept Of, Boston, MA 02115

Open in the dashboard

General payments

$68,981

238 records reported · program years 2019–2025

Research payments

$2,550

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Thomas Noh of Boston, MA is reported in the CMS Open Payments database as having received $68,981 across 238 general payments and $2,550 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,869 44
2024 General $1,916 23
2023 General $4,051 22
2023 Research $2,550 1
2022 General $22,214 50
2021 General $25,886 73
2020 General $8,949 16
2019 General $1,098 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thomas Noh
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Thomas Noh were reported at $4,869. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Thomas Noh Neurological Surgery median Middle half National median
2019 $1,098 $582 $138–$3,006 $163
2020 $8,949 $294 $76–$2,174 $114
2021 $25,886 $387 $105–$2,432 $132
2022 $22,214 $542 $139–$2,989 $149
2023 $4,051 $534 $145–$2,697 $160
2024 $1,916 $574 $155–$3,046 $164
2025 $4,869 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Spinal Elements, Inc. $18,471 25 payments
  2. Globus Medical, Inc. $15,868 29 payments
  3. Integrity Implants Inc $8,650 16 payments
  4. Alphatec Spine, Inc $6,918 32 payments
  5. Seaspine Orthopedics Corporation $3,508 24 payments
  6. First Gold Corp $3,500 2 payments
  7. Amplify Surgical, Inc. $3,160 14 payments
  8. Boston Scientific Corporation $2,552 20 payments
  9. Arthrex, Inc. $1,033 14 payments
  10. Elevate Surgical CO $909 7 payments
  11. Other $4,412 55 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $38,143 60 payments
  2. Consulting Fee $19,750 13 payments
  3. Food and Beverage $11,088 165 payments
Products named General payments · program years 2019–2025
  1. Karma $12,500 6 payments
  2. RISE $7,074 1 payment
  3. Medical Device $5,971 19 payments
  4. FlareHawk $5,539 2 payments
  5. EXCELSIUS GPS $5,368 12 payments
  6. Other - Miscellaneous $3,568 3 payments
  7. dualX $2,808 11 payments
  8. 4CIS PEEK PLIF Cage $2,500 1 payment
  9. 4CIS AUGUSTA PEEK ALIF CAGE $2,500 1 payment
  10. RISE-L $2,153 3 payments
  11. Other $18,945 186 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Skye Orthobiologics LLC $2,550 1 payment

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$7,322

Medicare's payments for the services billed

Medicare patients

17

Average age 72

Services billed

40

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
COPD 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
KRYSTEXXA
  • Amgen Inc. $20
$20 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

239 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record